Home
Flagship Pioneering Special Opportunities Fund II General Partner, 10% Owner: Omega Therapeutics OMGA Buy · Filed 23/02/27
Trade details
- Type
- Insider buy
- Amount
- $11,525,239.08
- Shares · price
- 1,993,986 sh · $5.78 a share
- Held after
- 7,508,693 sh
- Trade date
- 23/02/27
- Filed
- 23/02/27
- Days to filing
- 0 days
4 insiders bought this week
- Insiders buying this week
- 4 insiders
- Holding change
- +36.2%
Omega Therapeutics trades, last 26 weeks
What else happened in Omega Therapeutics around then
Filed or reported within 30 days of the trade day · 23/01/28~23/03/29Flagship Pioneering Special Opportunities Fund II General Partner's recent trades
- Flagship Pioneering Special Opportunities Fund II General Partner
BuyGenerate Biomedicines
BuyGenerate Biomedicines
GENB
$25M
1,562,500 sh
$25M
Filed 03/02
Traded 03/02
- Flagship Pioneering Special Opportunities Fund II General Partner
BuyGenerate Biomedicines
BuyGenerate Biomedicines
GENB
$25M
1,562,500 sh
$25M
Filed 03/02
Traded 03/02
- Flagship Pioneering Special Opportunities Fund II General Partner
BuyGenerate Biomedicines
BuyGenerate Biomedicines
GENB
$25M
1,562,500 sh
$25M
Filed 03/02
Traded 03/02
- Flagship Pioneering Special Opportunities Fund II General Partner
BuyOmega Therapeutics
BuyOmega Therapeutics
OMGA
$7.7M
1,329,324 sh
$7.7M
Filed 23/02/27
Traded 23/02/27